TB Research

Plasma CXCL8 and MCP-1 as biomarkers of latent tuberculosis infection

Sivaprakasam T Selvavinayagam, Bijulal Aswathy, Yean K. Yong, Asha Frederick, Lakshmi Murali, Vasudevan Kalaivani, Karishma S. Jith, Manivannan Rajeshkumar, et al. (23 authors)

medRxiv · 2023-08

Abstract

ABSTRACT Background Early detection of latent tuberculosis infection (LTBI) is critical to TB elimination in the current WHO vision of End Tuberculosis Strategy . Methods We investigated whether detecting plasma cytokines could aid in diagnosing LTBI across household contacts (HHCs) positive for IGRA, HHCs negative for IGRA, and healthy controls. We also measured the plasma cytokines using a commercial Bio-Plex Pro Human Cytokine 17-plex assay. Results Increased plasma CXCL8 and decreased MCP-1, TNF-α, and IFN-γ were associated with LTBI. Regression analysis showed that a combination of CXCL8 and MCP-1 increased the risk of LTBI among HHCs to 14-fold. Conclusions We postulated that CXCL8 and MCP-1 could be the surrogate biomarkers of LTBI, especially in resource-limited settings.

MeSH terms

  • Latent tuberculosis
  • Tuberculosis
  • Interleukin 8
  • Immunology
  • Medicine
  • Cytokine
  • Active tuberculosis
  • Mycobacterium tuberculosis